Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System

Purpose: Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients....

Full description

Saved in:
Bibliographic Details
Main Authors: Márcio Debiasi, Tomás Reinert, Rafael Kaliks, Gilberto Amorim, Maira Caleffi, Carlos Sampaio, Gustavo dos Santos Fernandes, Carlos H. Barrios
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2017-06-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.2016.005678
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items